PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human CCL28 (MEC) (carrier-free), 500 μg
Recombinant Human CCL3 (MIP-1α) (carrier-free), 10 μg
Recombinant Human CCL3 (MIP-1α) (carrier-free), 100 μg
Recombinant Human CCL3 (MIP-1α) (carrier-free), 25 μg
Recombinant Human CCL3 (MIP-1α) (carrier-free), 500 μg
Recombinant Human CCL3L1/ MIP-1α isoform LD78-β (carrier-free), 10 μg
Recombinant Human CCL3L1/ MIP-1α isoform LD78-β (carrier-free), 100 μg
Recombinant Human CCL3L1/ MIP-1α isoform LD78-β (carrier-free), 25 μg
Recombinant Human CCL4 (MIP-1β) (carrier-free), 10 μg
Recombinant Human CCL4 (MIP-1β) (carrier-free), 100 μg
Recombinant Human CCL4 (MIP-1β) (carrier-free), 25 μg
Recombinant Human CCL5 (RANTES) (Animal-Free), 20 μg
Recombinant Human CCL5 (RANTES) (carrier-free), 10 μg
Recombinant Human CCL5 (RANTES) (carrier-free), 100 μg
Recombinant Human CCL5 (RANTES) (carrier-free), 25 μg
Recombinant Human CCL5 (RANTES) (ELISA Std.), 4 pack